Genomind Supports Neuroscience Institute (NEI) with Grant to Further Knowledge of Personalized Medicine Among Health Professionals

Funding for New Interactive Learning Module Helps Clinicians Put Pharmacogenomics into Practice.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Chalfont, PA (PRWEB) May 24, 2012

Genomind, LLC. has awarded an education grant to the Neuroscience Education Institute (NEI) to further knowledge of personalized medicine among mental health professionals. The Genomind grant will support the development of NEI’s new Mixed Media Activity (MMA) entitled “Getting Personal: The Current Status of Genotyping in Psychiatry.”

Designed to explore the clinical applicability of genetic testing in psychiatry, the MMA will fill a critical education gap by helping clinicians integrate the principles of personalized medicine into practice. “Realizing the promise of personalized medicine requires a sustained commitment to advancing our understanding of underlying genetic and environmental bases of human disease,” said Dr. Stephen M. Stahl, Professor of Psychiatry at the University of California, San Diego School of Medicine and member of Genomind’s Scientific Advisory Board. “We are always looking at ways to translate these findings to real world medical products and practice.”

Developed to parallel a live NEI lecture, the MMA uses a dynamic mix of interactive cases and faculty-led presentations to engage participants and maintain their attention. A novel audience response tool provides the “best response” after a participant answers each question. Providing information on answers motivates participants and enables better retention of information.

The MMA program is self-directed, giving clinicians the freedom to start and stop the program at their convenience and complete their continuing medical education (CME) at their own pace.

“Genomind will continue to support educational initiatives for institutions like NEI, to further the potential application of genotyping to personalized treatment in psychiatry,” said Jay Lombard, DO, Chief Scientific Officer and Medical Director for Genomind.

Clinicians can visit http://www.neiglobal.com to learn more about NEI’s Mixed Media Activity.

About Genomind
Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders, and supports many initiatives that further the development of personalized medicine that improves patients’ lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research. Learn more at http://www.genomind.com.

About NEI
The Neuroscience Education Institute is a medical education company dedicated to providing evidence-based, fair and balanced activities to enhance the competency of participating mental health professionals. Founded in 2000 by award-winning author and psychiatrist Dr. Stephen M. Stahl, NEI provides interactive learning to mental health clinicians worldwide. Through NEI's fast-growing Global Psychopharmacology Congress, its web-based CME activities, and its online resources, NEI simplifies complex concepts to enhance understanding for US and international clinicians.


Contact

  • Doreen Korba
    Genomind, LLC
    215.396.5596
    Email